Mirum Pharmaceuticals Completes Acquisition of Bile Acid Product Portfolio for Treatment of Rare Liver Diseases from Travere Therapeutics Read more
Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia Read more
GSK’s regulatory submission accepted for review by Japanese regulator for use of Nucala (mepolizumab) in adults with chronic rhinosinusitis with nasal polyps Read more
7th IPF Summit: Advancing Insights and Collaboration in Pulmonary Fibrosis Research and Therapeutic Development Read more
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union Read more
Novo Nordisk acquires Embark Biotech, including its lead asset targeting obesity and other cardiometabolic diseases Read more
Zealand Pharma announces designation of priority review by the US FDA for dasiglucagon in congenital hyperinsulinism Read more
Roche’s Tecentriq becomes the first subcutaneous anti-PD-(L)1 cancer immunotherapy available to patients in Great Britain, reducing treatment time to just minutes Read more